Krystal Biotech
KRYS
KRYS
160 hedge funds and large institutions have $1.68B invested in Krystal Biotech in 2023 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 57 increasing their positions, 55 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
0.26% more ownership
Funds ownership: 81.18% → 81.44% (+0.26%)
9% less call options, than puts
Call options by funds: $10.6M | Put options by funds: $11.7M
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
Holders
160
Holding in Top 10
4
Calls
$10.6M
Puts
$11.7M
Top Buyers
| 1 | +$27.2M | |
| 2 | +$11M | |
| 3 | +$8.83M | |
| 4 |
NIP
Nicholas Investment Partners
Rancho Santa Fe,
California
|
+$8.62M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$7.05M |
Top Sellers
| 1 | -$25.4M | |
| 2 | -$22.2M | |
| 3 | -$10.2M | |
| 4 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
-$8.25M |
| 5 |
RCMNY
Rubric Capital Management (New York)
New York
|
-$7.34M |